MP Materials Corp (MP)vsMerck & Company Inc (MRK)

MP

MP Materials Corp

NYSE

$53.74

+0.84%

BASIC MATERIALS · Cap: $9.47B

MRK

Merck & Company Inc

NYSE

$119.37

+2.58%

HEALTHCARE · Cap: $287.71B

⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Merck & Company Inc generates 23501% more annual revenue ($65.01B vs $275.46M). MRK leads profitability with a 28.1% profit margin vs -31.2%. MRK earns a higher WallStSmart Score of 59/100 (C).

MP

Avoid

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 7.5

Piotroski: 4/9Altman Z: 1.13

MRK

Buy

out of 100

Grade: C

Growth: 4.0Profit: 9.5Value: 4.7Quality: 4.8

Piotroski: 3/9

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MP.

MRKSignificantly Overvalued (-141.2%)

Margin of Safety

-141.2%

Fair Value

$49.50

Current Price

$119.37

$69.87 premium

UndervaluedFair: $49.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MP1 strengths · Avg: 10.0/10

Revenue GrowthGrowth

70.0%10/10

Revenue surging 70.0% year-over-year

MRK6 strengths · Avg: 9.2/10

Market CapQuality

$287.71B10/10

Mega-cap, among the largest globally

Return on EquityProfitability

36.9%10/10

Every $100 of equity generates 37 in profit

Operating MarginProfitability

32.8%10/10

Strong operational efficiency at 32.8%

Profit MarginProfitability

28.1%9/10

Keeps 28 of every $100 in revenue as profit

P/E RatioValuation

16.0x8/10

Attractively priced relative to earnings

Free Cash FlowQuality

$1.82B8/10

Generating 1.8B in free cash flow

Areas to Watch

MP4 concerns · Avg: 2.0/10

Return on EquityProfitability

-5.0%2/10

ROE of -5.0% — below average capital efficiency

EPS GrowthGrowth

-55.6%2/10

Earnings declined 55.6%

Free Cash FlowQuality

$-109.26M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth

1.132/10

Distress zone — elevated risk

MRK3 concerns · Avg: 2.3/10

Piotroski F-ScoreQuality

3/93/10

Weak financial health signals

PEG RatioValuation

3.492/10

Expensive relative to growth rate

EPS GrowthGrowth

-19.3%2/10

Earnings declined 19.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : MP

The strongest argument for MP centers on Revenue Growth. Revenue growth of 70.0% demonstrates continued momentum.

Bull Case : MRK

The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.1% and operating margin at 32.8%.

Bear Case : MP

The primary concerns for MP are Return on Equity, EPS Growth, Free Cash Flow.

Bear Case : MRK

The primary concerns for MRK are Piotroski F-Score, PEG Ratio, EPS Growth.

Key Dynamics to Monitor

MP profiles as a hypergrowth stock while MRK is a value play — different risk/reward profiles.

MP carries more volatility with a beta of 1.62 — expect wider price swings.

MP is growing revenue faster at 70.0% — sustainability is the question.

MRK generates stronger free cash flow (1.8B), providing more financial flexibility.

Bottom Line

MRK scores higher overall (59/100 vs 29/100), backed by strong 28.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MP Materials Corp

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

MP Materials Corp. The company is headquartered in Las Vegas, Nevada.

Merck & Company Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.

Visit Website →

Compare with Other OTHER INDUSTRIAL METALS & MINING Stocks

MP vs BHP MP vs RIO MP vs VALE MP vs TECK MP vs USAR MRK vs BHP MRK vs RIO MRK vs VALE MRK vs TECK MRK vs USAR

Want to dig deeper into these stocks?

Full MP Analysis →Full MRK Analysis →